Southeast Alaska Regional Health Consortium is hosting a free presentation on Medicare to answer questions and help Sitkans 65 and over prepare to enroll in the program. Patient Health Benefits ...

today announced that Phase 1/2 interim readout data from its U.S. NXC-201 NEXICART-2 trial in relapsed/refractory AL Amyloidosis has been selected for oral presentation at the upcoming 2025 American ...

Marseille, France, April 23, 2025 10:00 a.m. ET / 4:00 p.m. CET– ImCheck Therapeutics announced today an oral presentation at the upcoming American Society of Clinical Oncology (ASCO ...

Additionally, two abstracts on another drug, AFM24, in combination with atezolizumab for treating non-small cell lung cancer (NSCLC) have been accepted for poster presentations. The oral ...

will be highlighted in an oral presentation. In addition, a trial-in-progress poster on SUPRAME, the ongoing Phase 3 clinical trial evaluating IMA203 in patients with unresectable or metastatic ...

Jaipur (Rajasthan) [India], April 21:SketchBubble, a leading provider of professionally designed presentation templates, proudly announces the launch of its new Free AI Presentation Maker, an ...

MOSCOW — The Latah County Human Rights Task Force and the Latah County Historical Society are sponsoring a free event Wednesday in Moscow featuring a presentation on Black women and their ...

But did you know that, until now, men haven’t had a real, hormone-free birth control option of ... It’s non-invasive and oral: No surgeries, no shots. Just a pill. The simplicity makes it ...

The free presentation will be from 1 to 2:30 p.m. on Thursday, April 10. Registration is required, the Alzheimer’s Association Minnesota-North Dakota Chapter said in a press release. Sisters ...

WAYNE, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and ...

Oral presentation to highlight preclinical data further supporting combination of KO-2806 with TKIs in ccRCC – – Company expects to present data from the Phase 1 FIT-001 trial evaluating KO-2806 and ...